Skip to main content
. 2021 Oct 3;9(10):e003499. doi: 10.1136/jitc-2021-003499

Figure 1.

Figure 1

Therapy regimen. Overview of the scheduled adoptive cell therapy in combination with conditioning chemotherapy, low-dose interleukin-2 and checkpoint inhibition. Created with BioRender.com. TIL, tumor-infiltrating lymphocyte.